Bleeding may be minor in the form of a small amount of red blood that is mixed in with the stool during an attack of diverticulitis, or the bleeding may be severe, involving the passage of dark clots of blood that may or may not happen during an attack of diverticulitis
What surprised you most
I dont think theres anything wrong with it
Popular brands like Wegovy, known for its weight management efficacy, and Ozempic, used for type 2 diabetes, are part of the semaglutide family
Reddys Laboratories focusing on complex generics and GLP-1 opportunities Zydus Lifesciences advancing peptide-based and metabolic treatments Cipla exploring chronic therapy expansion Lupin Limited investing in diabetes-focused portfolios This shift is already driving meaningful change: Improved affordability Increased accessibility Greater patient awareness At the same time, it raises important concerns: Risk of off-label use for cosmetic weight loss Need for stronger regulatory oversight Importance of patient education and adherence As a pharmacy student, I may be wrong, but from my understanding, this is more than just a market trend It reflects how innovation, affordability, and regulation must evolve together to shape responsible healthcare
